SCHEMBL8557809

SCHEMBL8557809

NNc1ncc(C(=O)Nc2cc(Cl)cc(Cl)c2)c(C(F)(F)F)n1

nearest known ligand 0.75

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 12/20 0.75
ATF1 P18846 9/20 0.75
XPO1 O14980 5/20 0.61
JUN P05412 4/20 0.61
NFKB2 Q00653 4/20 0.61
RELA Q04206 4/20 0.61
CNR2 P34972 4/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8542065 0.84 ATF1 (0.69) NFKB1ATF1XPO1JUNNFKB2
SCHEMBL541685 0.81 NFKB1 (0.65) NFKB1ATF1XPO1JUNNFKB2
SCHEMBL458841 0.76 NFKB1 (1.00) NFKB1ATF1XPO1JUNNFKB2
SCHEMBL3381215 0.76 CNR2 (0.60) NFKB1ATF1CNR2CYP3A4CYP2D6
SCHEMBL5083067 0.73 GAA (0.57) NFKB1ATF1CNR2CYP3A4CYP2D6
SCHEMBL3379898 0.73 CNR2 (0.64) NFKB1ATF1CNR2CYP3A4CYP2D6
SCHEMBL3380654 0.73 CNR2 (0.64) NFKB1ATF1CNR2CYP3A4CYP2D6
SCHEMBL6475927 0.72 MAPT (0.60) NFKB1ATF1JUNNFKB2RELA
SCHEMBL5083338 0.71 CNR2 (0.85) CNR2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL3379458 0.71 CNR2 (0.84) CNR2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811428-A ADMINISTERING FOR THE TREATMENT AND PREVENTION OF IMMUNOINFLAMMATORY AND AUTOIMMUNE DISEASES SIGNAL PHARMACEUTICALS, INC. (US) 1998-09-22 US claimed
US-5811428-A ADMINISTERING FOR THE TREATMENT AND PREVENTION OF IMMUNOINFLAMMATORY AND AUTOIMMUNE DISEASES SIGNAL PHARMACEUTICALS, INC. (US) 1998-09-22 US disclosed